Home
Conditions
Multiple Myeloma (MM)

Clinical trial condition

Multiple Myeloma (MM)

Explore clinical trials studying Multiple Myeloma (MM). Study availability and eligibility vary by location and protocol.

56 public trials 20 recruiting studies

Refine in advanced search Browse all conditions

Multiple Myeloma (MM) trial results

Not Yet Recruiting

MMulti-Immune HR; Multi-Target Immunotherapy for High-Risk Multiple Myeloma

NCT07029776

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Not Yet Recruiting

A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Multiple Myeloma（LB2505-0001）

NCT07399444

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Henan Cancer Hospital Zhengzhou, Henan, China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China

The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

The First Affiliated Hospital of Nanchang University Nanchang, Jiangxi, China

View Trial Details

Not Yet Recruiting

Effects of Controlled Breathing on Cardiorespiratory Variables in Multiple Myeloma

NCT07376733

Conditions: Blood Protein Disorders, Breathing Exercises, Breathing Techniques, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Application Study of 68Ga-NOTA-BCMA Nanoantibody Imaging in Multiple Myeloma

NCT07353554

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Peking Union Medical College Beijing, China

View Trial Details

Not Yet Recruiting

Effects of a Resistance Physical Exercise Program in Multiple Myeloma Patients

NCT07253103

Conditions: Behavior, Blood Protein Disorders, Cancer, +17 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

NCT07181239

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Not Yet Recruiting

A Clinical Study of BT02 in Patients With Relapsed or Refractory Hematologic Malignancies

NCT07107204

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

RN1201injection for Relapsed/Refractory CD19+/BCMA+ Hematologic Malignancies

NCT07113496

Conditions: B-cell Acute Lymphoblastic Leukemia (B-ALL), Blood Protein Disorders, Burkitt Lymphoma, +34 more
Locations: The First Affiliated Hospital with Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Not Yet Recruiting

Phase II Clinical Study on the Safety and Efficacy of Combined CAR-T Therapy Following Autologous Stem Cell Transplantation in Multiple Myeloma

NCT07034755

Conditions: Allogeneic Hematopoietic Stem Cell Transplantation (HSCT), Blood Protein Disorders, Cardiovascular Diseases, +15 more
Locations: The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China

View Trial Details

Not Yet Recruiting

Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions

NCT06720207

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Not specified

View Trial Details

Multiple Myeloma (MM)

Multiple Myeloma (MM) trial results

Related conditions